#78 – New Therapies in HIV: The Long Road to Long-acting Antiretrovirals - Are We There Yet?
Breakpoints
00:00
The Biggest Logistic Challenge for a Patient
The process basically is either the patient self-identifies in a clinic visit or calls clinic and says I want to hear more about this. Then that patient gets referred to myself I'm the keeper of all Kappa Tega Vereval Piviraine. Talk about a disincentive to use a treatment not only is it hard to set up and resource intensive but you're also going to have to pay thousands of dollars for this medication. Well clearly the fact that we're doing it shows that it's worth it for some people because if it were easy we'd probably have way more people on lung acting injector.
Transcript
Play full episode
